Monday, July 6, 2026
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
No Result
View All Result
Home Business

$30 Million In Cannabis Revenue To Go Towards THC Beverage Research in California

by Keegan MacDonald
January 8, 2026
in Business, Lifestyle, Politics
0
$30 Million In Cannabis Revenue To Go Towards THC Beverage Research in California
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

California officials have awarded nearly $30 million in new grants to support marijuana-focused academic research, expanding a state-funded effort to better understand cannabis use, regulation and its broader social and environmental impacts.

The latest awards, announced Monday by the Department of Cannabis Control (DCC), will fund a wide range of studies examining issues such as cannabis consumption among older adults, the effects of THC-infused beverages, the therapeutic potential of novel cannabinoids, the role of terpenes in product flavoring, tribal participation in the legal market and the environmental consequences of marijuana licensing programs.

The funding represents the third round of grants issued through the program, which is financed by state marijuana tax revenue. With this round, total distributions now approach $80 million.

According to DCC, the department received 149 research proposals and prioritized projects that demonstrated strong scientific rigor and the potential to improve public health, consumer safety and policymaking. Targeted research areas included education and prevention strategies, crop yields, consumer preferences, state and local cannabis policies, environmental sustainability and market dynamics.

“All research findings will be made available at no cost to the public to support broad access to rigorous, science-backed research while contributing to the national understanding of cannabis,” the department said in a press release.

Among the funded projects are several studies led by University of California campuses. UC San Diego researchers will examine how older adults choose cannabis products, focusing on factors such as potency, price and perceived safety, while a separate UC San Diego project will analyze how price changes and tax rates influence cannabis sales across more than 20 states.

UC San Francisco received funding for two major initiatives, including a clinical pharmacology study of commercially available THC-infused beverages and a project investigating how specific cannabinoids affect brain development, neuroinflammation and therapeutic pathways. UC Los Angeles researchers will study the synthesis and safety of novel cannabinoids, as well as naturally occurring flavor compounds to help regulators distinguish plant-derived terpenes from prohibited additives.

Other awards include UC Davis research into partnerships between the state and tribal cannabis markets, UC Berkeley studies on crop yields and environmental outcomes tied to licensure, and a San Diego State University occupational health study assessing pesticide and allergen exposure among cannabis workers.

Earlier grant rounds have examined topics such as delta-8 THC, legacy cannabis genetics and market competition. Separately, the state recently awarded more than $52 million in community reinvestment grants aimed at addressing the lasting impacts of marijuana prohibition.

Together, the programs reflect California’s continued effort to use cannabis tax revenue to support research, repair harms and strengthen a regulated legal market.

Read the whole article from Marijuanamoment here.

Views: 955
Previous Post

Arresting People for driving under the influence of weed is meaningless

Next Post

DEA States Marijuana Rescheduling Appeal Process ‘Still Pending’

Keegan MacDonald

Related Posts

Glass House Set To Begin Trading On NYSE

Glass House Set To Begin Trading On NYSE

by Keegan MacDonald
July 3, 2026
0

Glass House Group, one of California’s largest cannabis cultivators, is preparing to make history as its shares begin trading on...

Green Thumb Industries Marks Milestone as Second U.S. Cannabis Company Joins the NYSE

Green Thumb Industries Marks Milestone as Second U.S. Cannabis Company Joins the NYSE

by Keegan MacDonald
July 2, 2026
0

The Significance of Green Thumb Industries’ NYSE UplistingGreen Thumb Industries (GTI) will begin trading on the New York Stock Exchange...

How the Supreme Court’s Gun Rights Ruling is Shaping Marijuana User Cases Nationwide

by Keegan MacDonald
July 2, 2026
0

Breaking Down the Supreme Court’s Landmark DecisionIn a pivotal ruling, the U.S. Supreme Court has clarified the extent to which...

Marijuana Rescheduling Hearings Have Begun

Marijuana Rescheduling Hearings Have Begun

by Graham Cooper
June 29, 2026
0

Today, lawyers for the Drug Enforcement Administration have begun making the case for moving marijuana from Schedule I to Schedule...

Next Post
DEA States Marijuana Rescheduling Appeal Process ‘Still Pending’

DEA States Marijuana Rescheduling Appeal Process 'Still Pending'

How Terpenes and Receptors Shape Cannabis’s Entourage Effect

How Terpenes and Receptors Shape Cannabis’s Entourage Effect

July 3, 2026
How Cannabis May Support Lower Back Pain Relief and Reduce Opioid Use

How Cannabis May Support Lower Back Pain Relief and Reduce Opioid Use

July 3, 2026
Glass House Set To Begin Trading On NYSE

Glass House Set To Begin Trading On NYSE

July 3, 2026
ADVERTISEMENT
Sign up for the PP Newsletter

Categories

  • Age Restrictions
  • Air Travel
  • All Categories
  • Animal Health
  • Anxiety Relief
  • Bioplastics
  • Bipartisan Politics
  • Business
  • Cancer Care
  • Cancer Treatment
  • Cannabinoid Receptors
  • Cannabinoids
  • cannabis
  • Cannabis Brands
  • Cannabis Culture
  • Cannabis Finance
  • Cannabis Industry
  • Cannabis Legalization
  • Cannabis Market
  • Cannabis Policy
  • Cannabis Reform
  • Cannabis Regulation
  • Cannabis Research
  • Cannabis Tourism
  • Cannabis Travel
  • CB1 Receptor
  • CB2 Receptor
  • CBD
  • Colorado
  • Congress
  • Congressional Amendment
  • Consumer Health
  • Criminal Justice
  • Culture
  • Deceptive Marketing
  • Democrats
  • Donald Trump
  • Drug Policy
  • Employment Law
  • Endocannabinoid System
  • Entourage Effect
  • Environment
  • Featured
  • Federal Cannabis Law
  • Federal Cannabis Policy
  • Federal Law
  • Federal Lawsuit
  • Glioblastoma
  • Green Thumb Industries
  • Gun Rights
  • Health Research
  • Hemp
  • Illegal Market
  • Investors
  • Job Loss
  • John Fetterman
  • Kratom
  • Law Enforcement
  • Lawmakers
  • Legal Cannabis Industry
  • Legal Compliance
  • Legal Precedent
  • Legislation
  • Lifestyle
  • Lower Back Pain
  • Marijuana
  • Marijuana Clemency
  • Marijuana Extracts
  • Marijuana Legalization
  • Marijuana Policy
  • Marijuana Reform
  • Marijuana Regulation
  • Marijuana Users
  • Medical
  • Medical Cannabis
  • Medical Claims
  • Medical Marijuana
  • MJBizDaily
  • MSOs
  • New Jersey
  • North Carolina
  • NYSE
  • Opioid Reduction
  • Packaging
  • Pain Management
  • Pets
  • Policy
  • Politics
  • Pre-rolls
  • Product Safety
  • Psychedelics
  • Public Education
  • Public Safety
  • Regulatory Challenges
  • Retail Strategy
  • Second Amendment
  • Sleep Disorders
  • State Cannabis Officials
  • State Legalization
  • Supreme Court
  • Sustainability
  • Symptom Management
  • Terpenes
  • Testosterone
  • THC
  • TSA
  • uncategorized
  • Uplisting
  • US Cannabis
  • US Cannabis Market
  • Veterans
  • Veterans Affairs
  • World Cup 2024
  • Young Men

Recent Posts

  • How Terpenes and Receptors Shape Cannabis’s Entourage Effect
  • How Cannabis May Support Lower Back Pain Relief and Reduce Opioid Use

Browse by Tag

420 cannabis Edibles Legalization marijuana NORML THC

AFFILIATES

© Pot Portal. All rights reserved.

No Result
View All Result

© Pot Portal. All rights reserved.